KA
TDOC icon

Kovack Advisors’s Teladoc Health TDOC Stock Holding History

Kovack Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,337
Closed -$215K – 816
2021
Q4 		$215K Sell
2,337
-1,899
-45% -$227K 0.02% 641
2021
Q3 		$537K Buy
4,236
+561
+15% +$81.7K 0.06% 363
2021
Q2 		$611K Buy
3,675
+78
+2% +$12.6K 0.07% 303
2021
Q1 		$654K Sell
3,597
-473
-12% -$110K 0.09% 259
2020
Q4 		$814K Buy
4,070
+585
+17% +$119K 0.12% 192
2020
Q3 		$764K Buy
3,485
+456
+15% +$96.6K 0.14% 170
2020
Q2 		$578K Buy
3,029
+559
+23% +$98K 0.11% 194
2020
Q1 		$383K Buy
+2,470
New +$287K 0.09% 238

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Kovack Advisors's TDOC Position: Q1 2022 in Review

Kovack Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,337 shares — an estimated $215K sold.

Kovack Advisors first reported a position in TDOC in Q1 2020 and held it in 8 quarters. The position peaked at $814K in Q4 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Kovack Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Kovack Advisors sold 2,337 Teladoc Health shares in Q1 2022, an estimated $215K.
  • Kovack Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 8 quarters.
  • Kovack Advisors's Teladoc Health position peaked at $814K in Q4 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Kovack Advisors's 13F filing for Q1 2022, filed 16 May 2022.